SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-08-001971
Filing Date
2008-02-29
Accepted
2008-02-28 21:35:07
Documents
10
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K a2182934z10-k.htm 10-K 1288414
2 EXHIBIT 10.45 a2182934zex-10_45.htm EX-10.45 750397
3 EXHIBIT 12.1 a2182934zex-12_1.htm EX-12.1 18996
4 EXHIBIT 21 a2182934zex-21.htm EX-21 2834
5 EXHIBIT 23.1 a2182934zex-23_1.htm EX-23.1 4373
6 EXHIBIT 31.1 a2182934zex-31_1.htm EX-31.1 8007
7 EXHIBIT 31.2 a2182934zex-31_2.htm EX-31.2 7985
8 EXHIBIT 32.1 a2182934zex-32_1.htm EX-32.1 4547
9 EXHIBIT 32.2 a2182934zex-32_2.htm EX-32.2 4539
10 G27712KMI001.JPG g27712kmi001.jpg GRAPHIC 9569
  Complete submission text file 0001047469-08-001971.txt   2104817
Mailing Address 1110 SPRING ST SILVER SPRING MD 20910
Business Address 1110 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS CORP (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-26301 | Film No.: 08652643
SIC: 2834 Pharmaceutical Preparations